Earlier Treatment of Prostate Cancer

Media Center
‌
The treatment landscape in mHSPC has changed quite rapidly in the latest years. Listen to Dr Efstathiou’s thoughts on the past, present and future. (4:11 min) ►

Categories / tags

Related media

The role of modern imaging studies in men with PSA recurrence
Prof. Stefano Fanti, University of Bologna, Italy, explains the role of modern imaging in men with PSA recurrence following curative therapy.

(29:48 min) ►

CP-275093 updated 25.11.2021
TITAN Final Survival Analysis
Prof. Kim Chi, primary investigator of the TITAN study, explains some of the findings.

EM-61476 05.05.2021

Læs pligttekst her ERLEADA® (apalutamide)

Time 0:14-2.04 and 2:50-3:11: Chi KN, Chowdhury S, Bjartell A, et al. J Clin Oncol. 2021; JCO2003488. doi: 10.1200/JCO.20.03488. Online ahead of print. Time 2:20-2.45: Ferro M, Lucarelli G, Crocetto F, et al. Crit Rev Oncol Hematol. 2021; 157:103198.  

Developments within metastatic hormone sensitive prostate cancer
Treatment of newly diagnosed mHSPC and danish guidelines
Definition of non-metastatic castration-resistant prostate cancer (nmCRPC)
Non-metastatic castration resistant prostate cancer (nmCRPC)
Post-operative radiotherapy after radical prostatectomy
Prof. Chris Parker, Royal Marsden Hospital in Sutton, UK, share his views on timing, technique and concomitant treatment

(5:00 min) ►

CP-263408 updated 28.09.2021
Monitoring of Prostate Cancer Patients
In metastatic disease; why is it important to monitor your patient regularly and how do you do it. Dr Hervonen and Efsthathiou share their thoughts and experience on the topic. (4:57 min) ►
Is salvage procedures needed in all men with biochemical recurrence following curatively intend treatment?
Prof. Ola Bratt, University of Gothenburg, talk about the natural history of an increasing PSA and patient selection for salvage procedures

(4:50 min) ►

EM-74889 updated 28.09.2021
When to Change Treatment
If and when a patient shows progression or experiences adverse events. How do you know when and how to stop or change treatments?Dr Hervonen and Efsthathiou share their thoughts and experience on the topic. (4:19 min) ►
© Janssen-Cilag A/S. Denne side er publiceret af Janssen-Cilag A/S Danmark, som er ansvarlig for indholdet. Informationen på dette website er kun beregnet til Sundhedspersoner i Danmark.
Privacy PolicyLegal NoticeCookie Policy
Cookie Settings
Logo